Stock listing
BUX Stock Price, News, Filings & Events — Biomark Diagnostics, Inc.
Selected listing: BUX · NEO · CAD · CA
This page tracks Biomark Diagnostics, Inc.'s BUX:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BUX:NEO. BUX:NEO is the stock-level entry point for investors researching Biomark Diagnostics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biomark Diagnostics, Inc. (Ticker: BUX) is a public company based in Canada, specializing in innovative diagnostic solutions. With a market capitalization of approximately CAD 41.14 million, Biomark focuses on advancing healthcare through its proprietary technologies. The company aims to improve patient outcomes by providing accurate and timely diagnostic information.
- Ticker
- BUX:NEO
- Asset type
- Stock
- Market cap
- $38.6M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NEO
- Currency
- CAD
Biomark Diagnostics, Inc. BUX:NEO stock context
This page tracks Biomark Diagnostics, Inc.'s BUX:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BUX:NEO. BUX:NEO is the stock-level entry point for investors researching Biomark Diagnostics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biomark Diagnostics, Inc. (Ticker: BUX) is a public company based in Canada, specializing in innovative diagnostic solutions. With a market capitalization of approximately CAD 41.14 million, Biomark focuses on advancing healthcare through its proprietary technologies. The company aims to improve patient outcomes by providing accurate and timely diagnostic information.
Latest news from Biomark Diagnostics, Inc.
BioMark's Metabolomics Platform Captures Global Scientific Interest Following Publications Demonstrating Superior Diagnostic Performance ...
August 25, 2026
BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day
July 31, 2026
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test
June 23, 2026
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
April 14, 2026
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers i...
January 15, 2026
Research Biomark Diagnostics, Inc.
Biomark Diagnostics, Inc. investor report
Review AI stock analysis and investor report context for BUX:NEO.
Biomark Diagnostics, Inc. company profile
View the public company page for Biomark Diagnostics, Inc. on 6ix.
Biomark Diagnostics, Inc. news
Read company news and market updates connected to Biomark Diagnostics, Inc..
Biomark Diagnostics, Inc. investor events
Find investor webinars, events, and replay context for Biomark Diagnostics, Inc..
Alternate listings
BUX:CSE
CA · CAD
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.
BMKDF:OTC
US · USD
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.
A12EKB:LSX
DE · EUR
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.
A12EKB:LS
DE · EUR
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.
20B:FWB
DE · EUR
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.
20B:SWB
DE · EUR
Alternate listing for Biomark Diagnostics, Inc.; the primary context on this page is BUX:NEO.